
loading
|
Other customers were also interested in
|
loading
|
loading
|
loading
|
Anti-fungal and immunosuppressant. Selectively inhibits the mammalian target of rapamycin (mTOR) and blocks the subsequent activation of p70 S6 kinase (IC
50 = 50 pM). Specifically inhibits mTORC1, but mTORC2 that phosphorylates Akt at Ser
473 appears to be insensitive to rapamycin. Prevents the translational activation of IGF-II. Also prevents resting T-cells from entering the cell cycle, but does not directly arrest cell cycle progression. Shown to inhibit later signaling events, such as p110
Rb phosphorylation, p34
cdc2 kinase activation, and cyclin A synthesis. Exhibits strong binding to FK-506 binding proteins. Also reported to induce apoptosis in a murine B-cell line, to inhibit lymphokine-induced cell proliferation at the G
1 phase, and to irreversibly arrest Saccharomyces cerevisiae cells in the G
1 phase. A 5 mM (500 µg/109 µl) solution of Rapamycin (Cat. No.
553211) in DMSO and a 10 mM (1 mg/109 µl) solution of Rapamycin (Cat. No.
553212) in EtOH is also available.
|
Product information
|
|
Form
|
Clear film
|
|
Molar mass
|
914.2
|
|
Purity
|
≥98% by HPLC
|
|
Solubility
|
DMSO or MeOH
|
|
Chemical formula
|
C51H79NO13
|
|
RTECS
|
VE6250000
|
|
CAS number
|
53123-88-9
|
|
Merck USA index
|
14, 8114
|
|
Store and ship information
|
|
|
|
Storage
|
-20°C
|
|
Ship
|
Ambient Temperature Only
Standard Handling
|